Trendlines Group still a 'buy': DBS research


DBS Group Research has maintained its buy rating on The Trendlines Group, despite the Catalist-listed medical (medtech) and agricultural tech (agtech) incubator losing the bid to renew its agtech incubator licence.

It is "not a material loss", DBS analyst Sachin Mittal said in a note on Thursday....

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to